author-photo

Eloi Kpamegan

Novavax

8

Papers

590

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults

2017 Immunity & Ageing
Show All
- Source
- Cite
- Save
Citations (47)
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age

2017 Vaccine
Show All
- Source
- Cite
- Save
Citations (61)
Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs.

2015 Vaccine
Show All
- Source
- Cite
- Save
Citations (23)
Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus

2013 Vaccine
Show All
- Source
- Cite
- Save
Citations (98)
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.

2013 Vaccine
Show All
- Source
- Cite
- Save
Citations (113)
H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans

2011 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (83)